Targeted Pharmaceutical Patent Analysis
Custom Portfolio Analyses Available
Assuring Affordable Pharmaceuticals for All
We are dedicated to identifying patents cynically filed by big pharma that do not represent novel inventions worthy of protection . Such practice inflates pharma's bottom line at the expense of patients and others who might benefit from lowered drug prices.
Our Approach
Comprehensive Patent Reviews
Comprehensive Patent Reviews
Comprehensive Patent Reviews
The patent system was designed to be entrusted to authentic inventors and legitimate drug development organizations. However, many pharmaceutical filings are purposefully designed to artificially extend the reach of protection afforded by an efficient patent system. We have developed a comprehensive and multifaceted process for identify
The patent system was designed to be entrusted to authentic inventors and legitimate drug development organizations. However, many pharmaceutical filings are purposefully designed to artificially extend the reach of protection afforded by an efficient patent system. We have developed a comprehensive and multifaceted process for identifying pharmaceutical filings that make a mockery of the patent system. Once a potential candidate patent or patent group has been identified, we make every effort to expose those patents as neither unique nor useful.
Remedies
Comprehensive Patent Reviews
Comprehensive Patent Reviews
Our unique approach to helping prevent patent abuse lies in how the material we develop is ultimately leveraged after analysis. In addition to traditional judicial remedies such as filing petitions for Inter Partes review or other legal actions, our investigations can sometimes benefit from public dissemination in order for concerned or
Our unique approach to helping prevent patent abuse lies in how the material we develop is ultimately leveraged after analysis. In addition to traditional judicial remedies such as filing petitions for Inter Partes review or other legal actions, our investigations can sometimes benefit from public dissemination in order for concerned organizations and other coalitions worldwide to expand and focus upon our initial analysis. We feel that, while our team generates some of the best and most comprehensive studies available in the industry, our work can only improve with further public inquiry.
For the Benefit of Patients
Comprehensive Patent Reviews
For the Benefit of Patients
We are dedicated to improving durable and equitable competition in the prescription drug market, assuring fair and market-based pricing for all innovative and groundbreaking discoveries made by pharmaceutical companies that are beneficial to patients, physicians, and health care networks. We will fight for all who will benefit from fair a
We are dedicated to improving durable and equitable competition in the prescription drug market, assuring fair and market-based pricing for all innovative and groundbreaking discoveries made by pharmaceutical companies that are beneficial to patients, physicians, and health care networks. We will fight for all who will benefit from fair and equitable drug pricing but we will challenge any entity abusing the process to increase their profits at the expense of these same patients, physicians, and health care networks.
Current Opportunities - Completed Studies
We hope that interested parties, competitive pharmaceutical companies, and other stakeholders will use this freely available information to help bring down the cost of this drug for patients, hospitals, and caregivers. Reports presented here can be freely used as a basis for filing as IPRs, Para IV Certifications, etc.
Daybue Initial Patent Review U.S. 11370755 (pdf)
DownloadPress Release Study on Acadia's Daybue Patents (pdf)
DownloadScenesse Initial Patent Review 8334265 10076555 (pdf)
DownloadDolutegravir Initial Patent Review U.S. 8129385 (pdf)
DownloadLevulan Initial Patent Review U.S. 10357567 (pdf)
DownloadPress Release Study on Clinuvel's Scenesse Patents (pdf)
DownloadPress Release Study on ViiV Healthcare's Dolutegravir Patent (pdf)
DownloadPress Release Study on Sun Pharmaceuticals' LEVULAN KERASTICK (pdf)
DownloadThickets
Contact Us
International Patent Reviews, LLC
Our Associates
Copyright © 2024 International Patent Reviews, LLC - All Rights Reserved.
Powered by GoDaddy Website Builder
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.